When SSRIs fail: the neuromodulation pathway
Selective serotonin reuptake inhibitors (SSRIs) are considered the first-line, gold standard treatment for depression. However, their use is not without…
Analysis
The 2026 MedTech Forum: innovation and regulation lead the agenda
Why psychiatry needs better patient outcome data on medical cannabis
The 2026 MedTech Forum: Europe’s crisis preparedness takes the fore
Podcast: Supply chains, obesity drugs, and patents dominate Q1 earnings trends
Fast, Expert, Open: Lawrence Tallon’s vision for the MHRA
Hospital at home: the new model of modern care
Podcast: MHRA CEO Lawrence Tallon on the future of medical device regulation in the UK
